UPDATE 1-U.S. court dismisses Teva case to block copies of Copaxone

May 15 (Reuters) - A U.S. district court dismissed a case by Teva Pharmaceutical Industries Ltd against the U.S. Food and Drug Administration, part of the Israeli company's broad legal battle aimed at stopping generic versions of its Copaxone drug for multiple sclerosis.